1590403-33-0

Upstream product

• 761446-44-0 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole 
• 1590410-31-3 7-bromo-1-methyl-5-(4-(trifluoromethoxy)phenyl)-1,5-dihydro-4H-imidazo[4,5-c]pyridin-4-one 
• 1239719-69-7 2 -chloro-N-methyl-3-nitropyridin-4-amine 
• 50432-67-2 6-chloro-N₄-methyl-4,5-pyridinediamine 
• 73685-97-9 1-methyl-1,5-dihydro-4H-imidazo[4,5-c]pyridin-4-one 
• 5975-12-2 2,4-dichloro-3-nitro-pyridine 

Downstream Products

• 1590410-33-5 C₁₈H₁₄F₃N₅O₂*ClH 

Relevant academic research and scientific papers

PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME

Salts, hydrates and solvates of Compound I and methods of making and using the same and related dosage forms thereof are disclosed.

ANTI-FIBROTIC PYRIDINONES

This application relates to polycyclic compounds with a pyridinone or pyridinone derivative core including, substituted pyridinones, 5,6- and 6,6- bicyclic heterocycles and substituted pyridine-thiones. This application also discloses methods of preparing these polycyclic compounds, pharmaceutical compositions and medicaments comprising said compounds and methods to treat, prevent or diagnose diseases, disorders or conditions associated with fibrosis.

ANTI-FIBROTIC PYRIDINONES

Disclosed are pyridinone compounds, method for preparing these compounds, and methods for treating fibrotic disorders.